Publications - George P . Kim, M.D.

Back to Research Profile

1. Kim GP, Sargent DJ, Mahoney MR, Rowland KM Jr, Philip PA, Mitchell E, Mathews AP, Fitch TR, Goldberg RM, Alberts SR, Pitot HC. Phase III noninferiority trial comparing irinotecan with oxaliplatin, fluorouracil, and leucovorin in patients with advanced colorectal carcinoma previously treated with fluorouracil: N9841. J Clin Oncol 2009 Jun 10; 27(17):2848-54. Epub 2009 Apr 20.
   View PubMed
2. Stauffer JA, Dougherty MK, Kim GP, Nguyen JH. Interposition graft with polytetrafluoroethylene for mesenteric and portal vein reconstruction after pancreaticoduodenectomy. Br J Surg 2009 Mar; 96(3):247-52.
   View PubMed
3. Corsini MM, Miller RC, Haddock MG, Donohue JH, Farnell MB, Nagorney DM, Jatoi A, McWilliams RR, Kim GP, Bhatia S, Iott MJ, Gunderson LL. Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005). J Clin Oncol 2008 Jul 20; 26(21):3511-6.
   View PubMed
4. Kim GP, Grothey A. Targeting colorectal cancer with human anti-EGFR monoclonocal antibodies: focus on panitumumab. Biologics 2008 Jun; 2(2):223-8.
   View PubMed
5. Kim GP, Grothey A. Targeting colorectal cancer with human anti-EGFR monoclonal antibodies: focus on panitumumab. Biol Targets Ther 2008; 2(2):223-8.
   View PubMed
6. Bonatti H, Huguet K, McLaughlin S, Stockland A, Aranda-Michel J, Al Haddad M, Dougherty M, Fitzpatrick P, Kim G, Martin K, Hinder R, Nguyen JH. Whipple's procedure in a renal transplant recipient with polycystic liver disease. JOP 2008; 9(4):515-9. Epub 2008 Jul 10.
   View PubMed
7. Al-Haddad M, Martin JK, Nguyen J, Pungpapong S, Raimondo M, Woodward T, Kim G, Noh K, Wallace MB. Vascular resection and reconstruction for pancreatic malignancy: a single center survival study. J Gastrointest Surg 2007 Sep; 11(9):1168-74. Epub 2007 Jul 14.
   View PubMed
8. Alberts SR, Kim GP, Mahoney MR, Gornet MK, Rubin J, Ames M, Goetz MP, Weinshilboum RM, Nicol SJ, Goldberg RM. Pemetrexed and oxaliplatin for metastatic colorectal cancer: results of a phase I Mayo Cancer Center Research Consortium trial, MC0248. Clin Colorectal Cancer 2007 Jul; 6(8):572-7.
   View PubMed
9. Alberts SR, Gores GJ, Kim GP, Roberts LR, Kendrick ML, Rosen CB, Chari ST, Martenson JA. Treatment options for hepatobiliary and pancreatic cancer. Mayo Clin Proc 2007 May; 82(5):628-37.
   View PubMed
10. Kim GP, Erlichman C. Oxaliplatin. Expert Opin Drug Metab Toxicol 2007 Apr; 3(2):281-94.
    View PubMed
11. Kim GP, Erlichman C. Oxaliplatin in the treatment of colorectal cancer. Expert Opin Drug Metab Toxicol 2007 Apr; 3(2):281-94.
    View PubMed
12. Kim GP, Colangelo LH, Wieand HS, Paik S, Kirsch IR, Wolmark N, Allegra CJ, National Cancer Institute. Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative Study. J Clin Oncol 2007 Mar 1; 25(7):767-72.
    View PubMed
13. Pilot HC, Kim GP, Rowland KM, Sargent DJ, Philip PA, Mitchell EP, Goldberg RM, Alberts SR. A randomized phase III equivalence trial of irinotecan (CPT-11) versus oxaliplatin/5-fluorouracil (5FU)/leucovorin (FOLFOX4) in patients with advanced colorectal cancer previously treated with 5FU. Manuscript in preparation. 2007.
    View PubMed
14. Maples WJ, Sumrall SV, Woodward TA, Kim GP, Stevenson JP, Naughton M, Kauh J, Schwartz JD, Hamburg S, Harper G, Giudice RO. A phase 2 study of gemcitabine and thalidomide in patients with advanced pancreatic cancer. Manuscript submitted. 2007.
    View PubMed
15. Kim GP, Philip PA, Mahoney MR, Pitot HC, Fitch T, Picus J, Erlichman C. Phase II trial of PS-341 in unresectable hepatocellular carcinoma. Manuscript in preparation. 2007.
    View PubMed
16. Philip PA, Mahoney MR, Allmer C, Thomas J, Pitot HC, Kim G, Donehower RC, Fitch T, Picus J, Erlichman C. Phase II study of erlotinib in patients with advanced biliary cancer. J Clin Oncol 2006 Jul 1; 24(19):3069-74.
    View PubMed
17. Kim GP, Grothey A. Enhancing oxaliplatin-based regimens in colorectal cancer by inhibiting the epidermal growth factor receptor pathway. Clin Colorectal Cancer 2005 Nov; 5 Suppl 2:S89-97.
    View PubMed
18. Alberts SR, Foster NR, Morton RF, Kugler J, Schaefer P, Wiesenfeld M, Fitch TR, Steen P, Kim GP, Gill S. PS-341 and gemcitabine in patients with metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group (NCCTG) randomized phase II study. Ann Oncol 2005 Oct; 16(10):1654-61.
19. Philip PA, Mahoney MR, Allmer C, Thomas J, Pitot HC, Kim G, Donehower RC, Fitch T, Picus J, Erlichman C. Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer. J Clin Oncol 2005 Sep 20; 23(27):6657-63.
    View PubMed
20. Loprinzi CL, Levitt R, Barton DL, Sloan JA, Atherton PJ, Smith DJ, Dakhil SR, Moore DF, Krook JE, Rowland KM, Mazurczak MA, Berg AR, Kim GP. Evaluation of shark cartilage in patients with advanced cancer - A North Central Cancer Treatment Group trial. Cancer 2005 Jul 1; 104(1):176-82.
    View PubMed
21. Allegra CJ, Kim G, Kirsch IR. Microsatellite instability in colon cancer. N Engl J Med 2003 Oct 30; 349(18):1774-5.
    View PubMed
22. Allegra CJ, Paik S, Colangelo LH, Parr AL, Kirsch I, Kim G, Klein P, Johnston PG, Wolmark N, Wieand HS. Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study. J Clin Oncol 2003 Jan 15; 21(2):241-50.
    View PubMed
23. Sausville EA, El-Sayed Y, Monga M, Kim GP. Signal transduction directed cancer treatments. Annual Review of Pharmacology & Toxicology 2002.
24. Yoon SJ, Heo DS, Kang SH, Lee KH, Kim GP, Lee JA, Bang YJ, Kim NK. Natural killer cell activity depression in peripheral blood and ascites from gastric cancer patients with high TGF-beta 1 expression. Anticancer Research 1998; 18: 1591-6.
25. Kramer R, Zahker J, Kim G. Role of glutathione redox cycle in acquired and de novo multidrug resistance. Science 1988;214:694-7.
26. Kim GP, Colangelo LH, Wieand HS, Paik S, Kirsch IR, Wolmark N, Allegra CJ. Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative Study.[see comment]. J Clin Oncol 2007 Mar 1; 25(7):767-72.
    View PubMed